Updates are available Correction dated 2022-01-07
Click to view Correction: https://doi.org/10.1038/s41467-021-27678-7
-
Authors
Sun, Hua https://orcid.org/0000-0003-2169-0808
Cao, Song
Mashl, R. Jay
Mo, Chia-Kuei
Zaccaria, Simone https://orcid.org/0000-0002-5265-7392
Wendl, Michael C.
Davies, Sherri R. https://orcid.org/0000-0002-7141-8354
Bailey, Matthew H.
Primeau, Tina M.
Hoog, Jeremy
Mudd, Jacqueline L.
Dean, Dennis A. II
Patidar, Rajesh
Chen, Li
Wyczalkowski, Matthew A. https://orcid.org/0000-0003-4197-551X
Jayasinghe, Reyka G.
Rodrigues, Fernanda Martins
Terekhanova, Nadezhda V.
Li, Yize https://orcid.org/0000-0003-1074-281X
Lim, Kian-Huat https://orcid.org/0000-0002-2766-200X
Wang-Gillam, Andrea
Van Tine, Brian A. https://orcid.org/0000-0003-4572-6668
Ma, Cynthia X. https://orcid.org/0000-0002-8156-7492
Aft, Rebecca
Fuh, Katherine C.
Schwarz, Julie K. https://orcid.org/0000-0003-2407-7531
Zevallos, Jose P.
Puram, Sidharth V.
Dipersio, John F. https://orcid.org/0000-0002-0429-3133
,
Belmar, Julie
Held, Jason
Luo, Jingqin
Van Tine, Brian A.
Tipton, Rose
Wu, Yige
Yao, Lijun
Zhou, Daniel Cui
Butterfield, Andrew
Chu, Zhengtao
Fujita, Maihi
Yang, Chieh-Hsiang
Cortes-Sanchez, Emilio
Scherer, Sandra
Zhao, Ling
Borovski, Tijana
Chin, Vicki
DiGiovanna, John
Frech, Christian
Grover, Jeffrey
Jeon, Ryan
Koc, Soner
Randjelovic, Jelena
Seepo, Sara
Stankovic, Tamara
Dobrolecki, Lacey E.
Ittmann, Michael
Hilsenbeck, Susan G.
O’Malley, Bert W.
Mitsiades, Nicholas
Kaochar, Salma
Akcakanat, Argun
Augustine, Jithesh
Chen, Huiqin
Dai, Bingbing
Evans, Kurt W.
Gale, Kelly
Gibbons, Don
Ha, Min Jin
Jensen, Vanessa
Kim, Michael
Kirby, Bryce P.
Kopetz, Scott
Lanier, Christopher D.
Li, Dali
Majidi, Mourad
Menter, David
Meraz, Ismail
Saridogan, Turcin
Scott, Stephen
Sorokin, Alexey
Tapia, Coya
Wang, Jing
Westin, Shannon
Xi, Yuanxin
Xu, Yi
Yang, Fei
Yap, Timothy A.
Yennu-Nanda, Vashisht G.
Yuca, Erkan
Zhang, Jianhua
Zhang, Ran
Zhang, Xiaoshan
Zheng, Xiaofeng
Fingerman, Dylan
Lin, Haiyin
Liu, Qin
Kossenkov, Andrew V.
Rebecca, Vito W.
Somasundaram, Rajasekharan
Tetzlaff, Michae T.
Wickramasinghe, Jayamanna
Xiao, Min
Xu, Xiaowei
Bult, Carol J.
Robinson, Peter N.
Srivastava, Anuj
Lloyd, Michael W.
Neuhauser, Steven B.
Rubinstein, Jill
Sanderson, Brian J.
White, Brian
Woo, Xing Yi
Wallace, Tiffany
Minna, John D.
Boning, Gao
Girard, Luc
Park, Hyunsil
Timmons, Brenda C.
Nathanson, Katherine L.
Xu, George
Pan, Chong-xian
Chen Jr, Moon S.
Carvajal-Carmona, Luis G.
Cho, May
Coggins, Nicole B.
White, Ralph W. deVere
Polanco-Echeverry, Guadalupe
Estrada, Ana
Gandara, David R.
Kirane, Amanda R.
Le, Tiffany
Lott, Paul
Arana, Alexa Morales
Reiss, Jonathan W.
Rocha, Sienna
Tepper, Clifford G.
Toal, Ted
Zhang, Hongyong
Ma, Ai-Hong
Davis-Dusenbery, Brandi
Ellis, Matthew J.
Lewis, Michael T.
Davies, Michael A. https://orcid.org/0000-0002-0977-0912
Herlyn, Meenhard https://orcid.org/0000-0003-0839-0739
Fang, Bingliang
Roth, Jack A. https://orcid.org/0000-0002-8955-1313
Welm, Alana L. https://orcid.org/0000-0002-1412-1351
Welm, Bryan E.
Meric-Bernstam, Funda https://orcid.org/0000-0001-6816-6072
Chen, Feng
Fields, Ryan C.
Li, Shunqiang
Govindan, Ramaswamy
Doroshow, James H.
Moscow, Jeffrey A.
Evrard, Yvonne A. https://orcid.org/0000-0002-3475-4850
Chuang, Jeffrey H. https://orcid.org/0000-0002-3298-2358
Raphael, Benjamin J. https://orcid.org/0000-0003-1274-048X
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute
- License Information
-
More Information
Article History
Received: 16 February 2021
Accepted: 14 July 2021
First Online: 24 August 2021
Change Date: 7 January 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41467-021-27678-7
Competing interests
: The University of Utah may choose to license PDX models developed in the Welm labs, which may result in tangible property royalties to Drs. Welm and members of their labs who developed the models. M.T.L. is a founder and limited partner in StemMed Ltd. and a manager in StemMed Holdings, its general partner. He is a founder and equity stakeholder in Tvardi Theraeutics Inc. Some PDXs are exclusively licensed to StemMed Ltd. resulting in royalty income to M.T.L. L.E.D. is a compensated employee of StemMed Ltd. The other authors declare no competing interests.
: All patients were consented to the publishing of their de-identified clinical information. For further details, see Supplementary Methods.
: All of the xenograft studies were completed in accordance with animal research ethics regulations of each PDTC’s respective institutional review board. For further details, see the Supplementary Methods.
